Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3614)
All Articles published online
|
Feb 7, 2011 (publication date) through May 1, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang L, Li CL, Wang L, Yu WB, Yin HP, Zhang GY, Zhang LF, Li S, Hu SY. Influence of CXCR4/SDF-1 axis on E-cadherin/β-catenin complex expression in HT29 colon cancer cells. World J Gastroenterol 2011; 17(5): 625-632 [PMID: 21350711 DOI: 10.3748/wjg.v17.i5.625] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i5/625.htm |
| Number | Citing Articles |
| 1 |
Zhi-Yu Song, Feng Wang, Shu-Xiang Cui, Xian-Jun Qu. Knockdown of CXCR4 Inhibits CXCL12-Induced Angiogenesis in HUVECs through Downregulation of the MAPK/ERK and PI3K/AKT and the Wnt/β-Catenin Pathways. Cancer Investigation 2018; 36(1): 10 doi: 10.1080/07357907.2017.1422512
|
| 2 |
Nicolas Barry Delongchamps, Frédéric Beuvon, Jacques R. R. Mathieu, Stéphanie Delmas, Isabelle Metzger, Hervé Prats, Florence Cabon. CXCR4 is highly expressed at the tumor front but not in the center of prostate cancers. World Journal of Urology 2015; 33(2): 281 doi: 10.1007/s00345-014-1299-0
|
| 3 |
Priyanka Devi, Yerramsetti Nanaji, Nikita Khanna, Ashok Kumar Yadav, Sandip V. Pawar. Probiotic Research in Therapeutics. 2021; : 85 doi: 10.1007/978-981-33-6236-9_4
|
| 4 |
Ahmed Hjazi, Faryal Nasir, Rabia Noor, Ali Alsalamy, Rahman S. Zabibah, Rosario Mireya Romero-Parra, Muhammad Ikram Ullah, Yasser Fakri Mustafa, Maytham T. Qasim, Shaik Vaseem Akram. The pathological role of C-X-C chemokine receptor type 4 (CXCR4) in colorectal cancer (CRC) progression; special focus on molecular mechanisms and possible therapeutics. Pathology - Research and Practice 2023; 248: 154616 doi: 10.1016/j.prp.2023.154616
|
| 5 |
Yao Lu, Bin Hu, Guo-Feng Guan, Jie Chen, Chun-qiu Wang, Qiong Ma, Yan-Hua Wen, Xiu-Chun Qiu, Xiao-ping Zhang, Yong Zhou. SDF-1/CXCR4 promotes F5M2 osteosarcoma cell migration by activating the Wnt/β-catenin signaling pathway. Medical Oncology 2015; 32(7) doi: 10.1007/s12032-015-0576-0
|
| 6 |
Wen‐Bin Zhu, Zhi‐Feng Zhao, Xin Zhou. AMD3100 inhibits epithelial–mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF‐1α/CXCR4 signaling pathway in prostate cancer. Journal of Cellular Physiology 2019; 234(7): 11746 doi: 10.1002/jcp.27831
|
| 7 |
Doreen Heckmann, Patrick Maier, Stephanie Laufs, Frederik Wenz, W. Jens Zeller, Stefan Fruehauf, Heike Allgayer. CXCR4 Expression and Treatment with SDF-1α or Plerixafor Modulate Proliferation and Chemosensitivity of Colon Cancer Cells. Translational Oncology 2013; 6(2): 124 doi: 10.1593/tlo.12268
|
| 8 |
Ting-hua Hu, Yu Yao, Shuo Yu, Li-li Han, Wen-juan Wang, Hui Guo, Tao Tian, Zhi-pin Ruan, Xiao-min Kang, Jing Wang, Shu-hong Wang, Ke-jun Nan. SDF-1/CXCR4 promotes epithelial–mesenchymal transition and progression of colorectal cancer by activation of the Wnt/β-catenin signaling pathway. Cancer Letters 2014; 354(2): 417 doi: 10.1016/j.canlet.2014.08.012
|
| 9 |
Carlos A. Gonzalez-Villarreal, Adriana G. Quiroz-Reyes, Jose F. Islas, Elsa N. Garza-Treviño. Colorectal Cancer Stem Cells in the Progression to Liver Metastasis. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01511
|
| 10 |
Zhi-Yu Song, Zu-Hua Gao, Jia-Hui Chu, Xiu-Zhen Han, Xian-Jun Qu. Downregulation of the CXCR4/CXCL12 axis blocks the activation of the Wnt/β-catenin pathway in human colon cancer cells. Biomedicine & Pharmacotherapy 2015; 71: 46 doi: 10.1016/j.biopha.2015.01.020
|
| 11 |
Tao Shen, Zhibin Yang, Xianshuo Cheng, Youchuan Xiao, Kun Yu, Xinyi Cai, Cuifeng Xia, Yunfeng Li. CXCL8 induces epithelial-mesenchymal transition in colon cancer cells via the PI3K/Akt/NF-κB signaling pathway. Oncology Reports 2017; 37(4): 2095 doi: 10.3892/or.2017.5453
|
| 12 |
Barbara Mognetti, Giuseppe La Montagna, Maria Giulia Perrelli, Pasquale Pagliaro, Claudia Penna. Bone marrow mesenchymal stem cells increase motility of prostate cancer cells via production of stromal cell‐derived factor‐1α. Journal of Cellular and Molecular Medicine 2013; 17(2): 287 doi: 10.1111/jcmm.12010
|
| 13 |
Konrad Kwaśniak, Justyna Czarnik-Kwaśniak, Khrystyna Malysheva, Katarzyna Pogoda, Olexandr Korchynskyi, Paweł Rybojad, Bożenna Karczmarek-Borowska, Jacek Tabarkiewicz. LncCDH5-3:3 Regulates Apoptosis, Proliferation, and Aggressiveness in Human Lung Cancer Cells. Cells 2022; 11(3): 378 doi: 10.3390/cells11030378
|
| 14 |
Jian Qin, JiaAn Teng, Zhou Zhu, JiaXin Chen, Wen-Jun Huang. Genistein induces activation of the mitochondrial apoptosis pathway by inhibiting phosphorylation of Akt in colorectal cancer cells. Pharmaceutical Biology 2016; 54(1): 74 doi: 10.3109/13880209.2015.1014921
|
| 15 |
Xian-Shuo Cheng, Yun-Feng Li, Jing Tan, Bin Sun, You-Chuan Xiao, Xing-Bao Fang, Xiao-Feng Zhang, Qiang Li, Jian-Hua Dong, Ming Li, Hai-hua Qian, Zheng-Feng Yin, Zhi-Bin Yang. CCL20 and CXCL8 synergize to promote progression and poor survival outcome in patients with colorectal cancer by collaborative induction of the epithelial–mesenchymal transition. Cancer Letters 2014; 348(1-2): 77 doi: 10.1016/j.canlet.2014.03.008
|
| 16 |
Zhi-Yu Song, Zu-Hua Gao, Xian-Jun Qu. A review of CXCR4/CXCL12 axis in colorectal cancer. Biomedicine & Aging Pathology 2014; 4(3): 285 doi: 10.1016/j.biomag.2014.06.001
|
| 17 |
Aïssata Aimée Goïta, Dominique Guenot. Colorectal Cancer: The Contribution of CXCL12 and Its Receptors CXCR4 and CXCR7. Cancers 2022; 14(7): 1810 doi: 10.3390/cancers14071810
|
| 18 |
Amirhosein Maharati, Meysam Moghbeli. PI3K/AKT signaling pathway as a critical regulator of epithelial-mesenchymal transition in colorectal tumor cells. Cell Communication and Signaling 2023; 21(1) doi: 10.1186/s12964-023-01225-x
|
| 19 |
Aldo M. Roccaro, Antonio Sacco, Cristina Jimenez, Patricia Maiso, Michele Moschetta, Yuji Mishima, Yosra Aljawai, Ilyas Sahin, Michelle Kuhne, Pina Cardarelli, Lewis Cohen, Jesus F. San Miguel, Ramon Garcia-Sanz, Irene M. Ghobrial. C1013G/CXCR4 acts as a driver mutation of tumor progression and modulator of drug resistance in lymphoplasmacytic lymphoma. Blood 2014; 123(26): 4120 doi: 10.1182/blood-2014-03-564583
|
| 20 |
Kyoko Yamaguchi, Tomoyasu Yoshihiro, Hiroshi Ariyama, Mamoru Ito, Michitaka Nakano, Yuichiro Semba, Jumpei Nogami, Kenji Tsuchihashi, Takuji Yamauchi, Shohei Ueno, Taichi Isobe, Koji Shindo, Taiki Moriyama, Kenoki Ohuchida, Masafumi Nakamura, Yoshihiro Nagao, Tetsuo Ikeda, Makoto Hashizume, Hiroyuki Konomi, Takehiro Torisu, Takanari Kitazono, Tomohiro Kanayama, Hiroyuki Tomita, Yoshinao Oda, Hitoshi Kusaba, Takahiro Maeda, Koichi Akashi, Eishi Baba. Potential therapeutic targets discovery by transcriptome analysis of an in vitro human gastric signet ring carcinoma model. Gastric Cancer 2022; 25(5): 862 doi: 10.1007/s10120-022-01307-8
|
| 21 |
Émilie C. Lefort, Jonathan Blay. Apigenin and its impact on gastrointestinal cancers. Molecular Nutrition & Food Research 2013; 57(1): 126 doi: 10.1002/mnfr.201200424
|
| 22 |
Zeng Li, Nan Li, Minghua Wu, Xiayu Li, Zhaohui Luo, Xiaoyan Wang. Expression of miR-126 suppresses migration and invasion of colon cancer cells by targeting CXCR4. Molecular and Cellular Biochemistry 2013; 381(1-2): 233 doi: 10.1007/s11010-013-1707-6
|